These values are comparable to another study by Yamashita et al., wherein a sensitivity and specificity of 57.3 and 85.3%, respectively, was observed for predicting HNSCC using serum midkine levels as a bio-marker [31]. The gene discussed is MDK; the disease is head and neck squamous cell carcinoma.